White label – Pompe disease - ClinicalTrials.eu

Study on Doxorubicin, Fluorouracil, and Oxaliplatin for Children and Adolescents with Primary Malignant Liver Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Hepatoblastoma
Investigated Drugs:
Study on Dimethyl Fumarate for Patients with Mild Cognitive Impairment and Alzheimer’s Disease

Recruiting

2 1 1 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Dimethyl Fumarate
Study of Pembrolizumab Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme Patients

Recruiting

3 1 1 1
Investigated Drugs:
- Pembrolizumab
Study of Asciminib treatment for patients with Chronic Myeloid Leukemia who have T315I mutation and cannot take or tolerate ponatinib

Recruiting

2 1 1 1
Investigated Diseases:
- Chronic myeloid leukaemia
Investigated Drugs:
- Asciminib Hydrochloride
Study on Dexmedetomidine and Sodium Chloride for Pain Management in Children Undergoing Surgery with Local Anesthesia

Recruiting

2 1 1
Investigated Drugs:
- Dexmedetomidine
- Sodium Chloride
Study of Nivolumab and Chemotherapy Combination for Patients with Refractory Hodgkin’s Lymphoma

Recruiting

2 1 1 1
Investigated Diseases:
- Hodgkin’s disease refractory
Investigated Drugs:
- Nivolumab
Study on the Safety and Effectiveness of Patritumab Deruxtecan for Patients with Colorectal, Biliary Tract, and Liver Cancer

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Patritumab Deruxtecan
Study of Drug Combination for Advanced Cancer Patients with Known Molecular Profile – FINPROVE Study

Recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
Study on the Effects of Methylprednisolone and Prednisone for Treating Acute Flare-Ups in Idiopathic Pulmonary Fibrosis Patients

Recruiting

2 1 1
Investigated Diseases:
- Idiopathic pulmonary fibrosis
Investigated Drugs:
Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies